GMIM
AMRI

General Motors Investment Management’s Albany Molecular Research Inc AMRI Stock Holding History

General Motors Investment Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-13,289
Closed -$247K – 1079
2014
Q1 		$247K Sell
13,289
-1,248
-9% -$17.2K 0.02% 735
2013
Q4 		$147K Buy
+14,537
New +$176K 0.01% 893

Other funds holding AMRI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

General Motors Investment Management's AMRI Position: Q2 2014 in Review

General Motors Investment Management sold out of Albany Molecular Research Inc (AMRI) in Q2 2014, closing a stake of 13,289 shares — an estimated $247K sold.

General Motors Investment Management first reported a position in AMRI in Q4 2013 and held it in 2 quarters. The position peaked at $247K in Q1 2014. 132 funds tracked by Wall St. Rank hold AMRI as of Q2 2014.

  • General Motors Investment Management reported no remaining Albany Molecular Research Inc position as of Q2 2014 after selling out during the quarter.
  • General Motors Investment Management sold 13,289 Albany Molecular Research Inc shares in Q2 2014, an estimated $247K.
  • General Motors Investment Management first reported a position in Albany Molecular Research Inc in Q4 2013 and held it in 2 quarters.
  • General Motors Investment Management's Albany Molecular Research Inc position peaked at $247K in Q1 2014.
  • 132 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2014.

Based on General Motors Investment Management's 13F filing for Q2 2014, filed 8 Aug 2014.